chr9-37529211-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012166.3(FBXO10):āc.1619A>Gā(p.Asn540Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,613,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012166.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO10 | NM_012166.3 | c.1619A>G | p.Asn540Ser | missense_variant | 5/11 | ENST00000432825.7 | NP_036298.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO10 | ENST00000432825.7 | c.1619A>G | p.Asn540Ser | missense_variant | 5/11 | 1 | NM_012166.3 | ENSP00000403802 | P1 | |
FBXO10 | ENST00000543968.5 | n.271A>G | non_coding_transcript_exon_variant | 3/6 | 3 | |||||
FBXO10 | ENST00000276960.7 | c.1619A>G | p.Asn540Ser | missense_variant, NMD_transcript_variant | 5/9 | 5 | ENSP00000276960 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 247914Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134470
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461086Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 726718
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.1619A>G (p.N540S) alteration is located in exon 5 (coding exon 4) of the FBXO10 gene. This alteration results from a A to G substitution at nucleotide position 1619, causing the asparagine (N) at amino acid position 540 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at